Company / R&D per Share
MEDICINOVA INC R&D per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.14
FY2025
5-year range
$0.11 / $0.18
FY2021-FY2025
Trend
+26.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share returned to growth in FY2025 after 3 years of decline, reaching $0.14.
Based on SEC 10-K filings.
0.14 in FY2025 with a 3-year CAGR of -8.3%.
Declined from $0.18 to $0.14 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -8.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 26.4% year-over-year.
- Peak r&d per share was recorded in FY2011.
- Lowest r&d per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.14 | +26.4% |
| FY2024 | $0.11 | -39.1% |
| FY2023 | $0.18 | -0.0% |
| FY2022 | $0.18 | -1.4% |
| FY2021 | $0.18 | +39.6% |
| FY2014 | $0.13 | -50.1% |
| FY2013 | $0.26 | -46.6% |
| FY2012 | $0.48 | -22.7% |
| FY2011 | $0.63 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026